Willingness to pay for hormone replacement therapy

Niklas Zethraeus

Health Economics, 1998, vol. 7, issue 1, 31-38

Abstract: This study addresses the question of willingness to pay (WTP) for hormone replacement therapy (HRT) in order to alleviate menopausal symptoms. The woman obtains utility from consumption of goods and health. The purchase of a treatment is represented as a shift in the health production function during the treatment period. The mean WTP for the HRT is estimated using a parametric and a non‐parametric method. The mean WTP based on these two methods is similar in both cases and amounts to about SEK 40 000 per year. Further, it is shown that the mean WTP is above the mean treatment cost of HRT. Finally, the implied WTP per gained quality adjusted life year (QALY) is estimated at about SEK 120 000 and SEK 160 000 based on the rating scale (RS) and time trade‐off (TTO) methods, respectively. © 1998 John Wiley & Sons, Ltd.

Date: 1998
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (20)

Downloads: (external link)
https://doi.org/10.1002/(SICI)1099-1050(199802)7:13.0.CO;2-7

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:7:y:1998:i:1:p:31-38

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().